Carboxy Therapy Market: Current Analysis and Forecast (2022-2028)

Carboxy Therapy Market: Current Analysis and Forecast (2022-2028)

The carboxytherapy market is expected to register a CAGR of approx. 12% over the period of 2022-2028. Carboxy therapy, also referred to as carbon dioxide therapy, involves injecting a tiny amount of CO2 gas under the skin. When carbon dioxide gas is injected into the treatment area, it dilates blood vessels, increasing circulation and stimulating collagen formation. As a result, the skin renews and reconditions itself. Furthermore, inflammation is reduced, and cellular regeneration is boosted. The most common way for a healthcare professional to administer this treatment is via injection. However, topical versions of carbon dioxide treatment allow patients to reap the benefits on their own at home. The growing demand for carboxytherapy can be attributed to the rise in the geriatric population and the increasing demand for aesthetic attractiveness enhancement across the globe. For instance, in 2020, according to the International Society of Aesthetic Plastic Surgery (ISAPS) global survey, there were 14,400,347 nonsurgical procedures performed worldwide. Owing to the glaring statistics the increasing availability of a wide range of such treatment options across the globe is leading to the growing demand for carboxy therapy and would contribute to the growth of the market in the forthcoming period as well. In addition, increasing physician and patient awareness about the therapeutic advantages of carboxy therapy units are likely to aid market growth. Furthermore, the carboxy therapy market is anticipated to grow on account of outpatient operations becoming more popular amongst healthcare institutions such as hospitals and clinics due to the availability of minimally invasive techniques such as carboxy therapy. However, some of the restraints in the market including the strict regulatory policies and safety concerns associated with carboxytherapy are impeding the growth of this market all over the world.

• Based on the product, the carboxy therapy market is segmented into tabletop, portable, and others. The tabletop segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe due to its wide application in pain management and medical aesthetics.
• Based on the application, the market is fragmented into aesthetic medicine, dermatology, gynecology, angiology, orthopedics & rheumatology, sports medicine, and others. The aesthetics medicine segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the increasing use of carboxy therapy for aesthetic procedures such as facial lines, wrinkles on the face, lip lines, etc. Factors like growing awareness about aesthetic procedures and rising disposable income are expected to boost market growth.
• Based on the end-users, the market is fragmented into hospitals, aesthetic clinics, and beauty centers. The hospital segment grabbed a considerable market share and is expected to grow at a significant CAGR during the forecast period. Many aesthetic procedures, particularly breast procedures, blepharoplasty, and other minimally invasive procedures, are performed in hospitals. Mainly due to the global rise in obesity, as well as the high income, and advanced healthcare infrastructure there is an increased growth rate of the hospital segment.
• For a better understanding of the market adoption of carboxy therapy, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the carboxy therapy industry owing to the higher awareness of aesthetic surgical procedures, technological advancements in cosmetic procedures, presence of key market players, increasing geriatric population, and growing demand for non-invasive aesthetic procedures.
• Some of the major players operating in DTA Medical, Cosmo Pro Ltd., Carbossiterapia Italiana, Beijing Jontelaser Technologies Co., Ltd., Kastner-Praxisbedarf, Mezopharma, MBE Medical Division, Nick Fanavaran Plasma Company, Air Liquide Healthcare, Alvi Prague among others. Several M&A’s along with partnerships have been undertaken by these players.